Literature DB >> 10067851

Increased osteoblastic c-fos expression by parathyroid hormone requires protein kinase A phosphorylation of the cyclic adenosine 3',5'-monophosphate response element-binding protein at serine 133.

D R Tyson1, J T Swarthout, N C Partridge.   

Abstract

PTH induces c-fos expression rapidly and transiently in osteoblastic cells and requires the activity of the cAMP response element-binding protein (CREB). Here we provide evidence that protein kinase A (PKA) is the enzyme responsible for phosphorylating CREB at serine 133 (S133) and that this event is required for PTH-induced c-fos expression. PTH increases the level of phosphorylation of CREB at S133 in a time- and dose-dependent manner, correlating with the time and level of activation of PKA in response to PTH. PTH-(1-34) and -(1-31), each known to activate the cAMP pathway, induced the phosphorylation of CREB and increased the levels of c-fos messenger RNA, whereas PTH-(3-34), -(13-34), and -(28-48) could not. Specific inhibitors of calcium/calmodulin-dependent protein kinases and protein kinase C could not inhibit CREB phosphorylation or c-fos expression in response to PTH; however, H-89, a specific inhibitor of PKA, could do so in a dose-dependent manner. In addition, PTH-induced c-fos promoter activity was completely inhibited in a dose-dependent fashion by transfection of the heat-stable inhibitor of PKA. Taken together, these data provide strong evidence that PKA is the enzyme responsible for phosphorylating CREB at S133 in response to PTH and that PKA activity is required for PTH-induced c-fos expression.

Entities:  

Keywords:  Non-programmatic

Mesh:

Substances:

Year:  1999        PMID: 10067851     DOI: 10.1210/endo.140.3.6567

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  20 in total

Review 1.  PTH and PTHrP effects on the skeleton.

Authors:  A C Karaplis; D Goltzman
Journal:  Rev Endocr Metab Disord       Date:  2000-11       Impact factor: 6.514

2.  Anabolic action of parathyroid hormone regulated by the β2-adrenergic receptor.

Authors:  Ryo Hanyu; Vanessa L Wehbi; Tadayoshi Hayata; Shuichi Moriya; Timothy N Feinstein; Yoichi Ezura; Masashi Nagao; Yoshitomo Saita; Hiroaki Hemmi; Takuya Notomi; Tetsuya Nakamoto; Ernestina Schipani; Shu Takeda; Kazuo Kaneko; Hisashi Kurosawa; Gerard Karsenty; Henry M Kronenberg; Jean-Pierre Vilardaga; Masaki Noda
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-25       Impact factor: 11.205

3.  Overexpression of the transcriptional factor Runx2 in osteoblasts abolishes the anabolic effect of parathyroid hormone in vivo.

Authors:  Didier Merciris; Caroline Marty; Corinne Collet; Marie-Christine de Vernejoul; Valerie Geoffroy
Journal:  Am J Pathol       Date:  2007-05       Impact factor: 4.307

4.  Parathyroid hormone signaling through low-density lipoprotein-related protein 6.

Authors:  Mei Wan; Chaozhe Yang; Jun Li; Xiangwei Wu; Hongling Yuan; Hairong Ma; Xi He; Shuyi Nie; Chenbei Chang; Xu Cao
Journal:  Genes Dev       Date:  2008-11-01       Impact factor: 11.361

5.  In vivo targeted deletion of calpain small subunit, Capn4, in cells of the osteoblast lineage impairs cell proliferation, differentiation, and bone formation.

Authors:  Masako Shimada; Peter A Greer; Andrew P McMahon; Mary L Bouxsein; Ernestina Schipani
Journal:  J Biol Chem       Date:  2008-05-30       Impact factor: 5.157

6.  Identification of O-linked N-acetylglucosamine (O-GlcNAc)-modified osteoblast proteins by electron transfer dissociation tandem mass spectrometry reveals proteins critical for bone formation.

Authors:  Alexis K Nagel; Michael Schilling; Susana Comte-Walters; Mary N Berkaw; Lauren E Ball
Journal:  Mol Cell Proteomics       Date:  2013-02-26       Impact factor: 5.911

7.  Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.

Authors:  Changjun Li; Qiujuan Xing; Bing Yu; Hui Xie; Weishan Wang; Chenhui Shi; Janet L Crane; Xu Cao; Mei Wan
Journal:  J Bone Miner Res       Date:  2013-10       Impact factor: 6.741

8.  Runx2 recruits p300 to mediate parathyroid hormone's effects on histone acetylation and transcriptional activation of the matrix metalloproteinase-13 gene.

Authors:  Christine E Boumah; Minnkyong Lee; Nagarajan Selvamurugan; Emi Shimizu; Nicola C Partridge
Journal:  Mol Endocrinol       Date:  2009-05-07

9.  Inhibition of Ca²⁺/calmodulin-dependent protein kinase kinase 2 stimulates osteoblast formation and inhibits osteoclast differentiation.

Authors:  Rachel L Cary; Seid Waddell; Luigi Racioppi; Fanxin Long; Deborah V Novack; Michael J Voor; Uma Sankar
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

10.  Abaloparatide at the Same Dose Has the Same Effects on Bone as PTH (1-34) in Mice.

Authors:  Carole Le Henaff; Florante Ricarte; Brandon Finnie; Zhiming He; Joshua Johnson; Johanna Warshaw; Victoria Kolupaeva; Nicola C Partridge
Journal:  J Bone Miner Res       Date:  2019-12-27       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.